{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:07:40Z","timestamp":1788912460912,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04622-9","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:44:02Z","timestamp":1782362642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of PAX1\/JAM3 gene methylation, HR-HPV, and TCT with high-grade cervical lesions in a high-risk cohort: a multinomial logistic regression analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Tongyao","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"26","key":"4622_CR1","first-page":"3314","volume":"28","author":"SHANG Zhonghua","year":"2025","unstructured":"Zhonghua SHANG, et al. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035. Chin Gen Pract [J]. 2025;28(26):3314\u201320.","journal-title":"Chin Gen Pract [J]"},{"issue":"5","key":"4622_CR2","first-page":"649","volume":"25","author":"ZHAO Yun","year":"2023","unstructured":"Yun ZHAO, et al. Screening for cervical cancer and diversion of abnormal screening results. J Chin Physician [J]. 2023;25(5):649\u201351. 655.).","journal-title":"J Chin Physician [J]"},{"issue":"5","key":"4622_CR3","first-page":"641","volume":"25","author":"CAI Jing","year":"2023","unstructured":"Jing CAI, Zehua WANG. Challenges in screening and early detection of gynecologic malignancies. J Chin Physician [J]. 2023;25(5):641\u20133.","journal-title":"J Chin Physician [J]"},{"issue":"11","key":"4622_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41416-025-03005-5","volume":"132","author":"H Su","year":"2025","unstructured":"Su H, et al. The triage role of cytological DNA methylation in women with non-16\/18, specifically genotyping high-risk HPV infection. Br J Cancer. 2025;132(11):1064\u201371.","journal-title":"Br J Cancer"},{"issue":"6","key":"4622_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jasc.2021.05.002","volume":"10","author":"S Narkcham","year":"2021","unstructured":"Narkcham S, et al. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping. J Am Soc Cytopathol. 2021;10(6):558\u201364.","journal-title":"J Am Soc Cytopathol"},{"issue":"8","key":"4622_CR6","first-page":"CD008587","volume":"8","author":"G Koliopoulos","year":"2017","unstructured":"Koliopoulos G, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):CD008587.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"4622_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/ijc.35406","volume":"157","author":"SJ Bowden","year":"2025","unstructured":"Bowden SJ, et al. DNA methylation signatures of cervical pre-invasive and invasive disease: An epigenome-wide association study. Int J Cancer. 2025;157(2):305\u201316.","journal-title":"Int J Cancer"},{"issue":"8","key":"4622_CR8","doi-asserted-by":"publisher","first-page":"101794","DOI":"10.1016\/j.gore.2025.101794","volume":"60","author":"R Zhang","year":"2025","unstructured":"Zhang R, et al. PAX1\/SOX1 gene methylation as a detection and triage method for triage of high risk HPV-Positive women in cervical cancer screening. Gynecol Oncol Rep. 2025;60(8):101794.","journal-title":"Gynecol Oncol Rep"},{"issue":"12","key":"4622_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/17501911.2025.2535942","volume":"17","author":"H Wang","year":"2025","unstructured":"Wang H, et al. Epigenetic silencing of JAM3 promoted progression in serous ovarian carcinoma through PI3K\/AKT pathway. Epigenomics. 2025;17(12):803\u201315.","journal-title":"Epigenomics"},{"issue":"1","key":"4622_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1186\/s12885-024-13299-y","volume":"24","author":"D Sun","year":"2024","unstructured":"Sun D, et al. The performance of JAM3\/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection. BMC Cancer. 2024;24(1):1514.","journal-title":"BMC Cancer"},{"issue":"1","key":"4622_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13148-024-01804-w","volume":"16","author":"L Jing Fei","year":"2024","unstructured":"Jing Fei L, Zhai,Jing, Wang, et al. Evaluating PAX1\/JAM3 methylation for triage in HPV 16\/18-infected women. Clin Epigenetics. 2024;16(1):190. https:\/\/doi.org\/10.1186\/s13148-024-01804-w.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"4622_CR12","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"30","key":"4622_CR13","doi-asserted-by":"publisher","first-page":"e43384","DOI":"10.1097\/MD.0000000000043384","volume":"104","author":"S Hu","year":"2025","unstructured":"Hu S, et al. Risk factors for hrHPV infection with cervical lesions patient in Anhui Province of China from 2021 to 2024: A retrospective study. Med (Baltim). 2025;104(30):e43384.","journal-title":"Med (Baltim)"},{"issue":"1","key":"4622_CR14","first-page":"26","volume":"16","author":"SU Mingrui","year":"2024","unstructured":"Mingrui SU, et al. Characteristics of vaginal microbiota in various cervical lesions in women infected with HR-HPV species alpha-9. Chin J Front Med Science(Electronic Version) [J]. 2024;16(1):26\u201335.","journal-title":"Chin J Front Med Science(Electronic Version) [J]"},{"issue":"2","key":"4622_CR15","doi-asserted-by":"publisher","first-page":"821453","DOI":"10.3389\/fonc.2022.821453","volume":"12","author":"L Sun","year":"2022","unstructured":"Sun L, et al. Optimization of Cervical Cancer Screening: A Stacking-Integrated Machine Learning Algorithm Based on Demographic, Behavioral, and Clinical Factors. Front Oncol. 2022;12(2):821453.","journal-title":"Front Oncol"},{"issue":"5","key":"4622_CR16","first-page":"548","volume":"41","author":"HUANG Junting","year":"2025","unstructured":"Junting HUANG, et al. A clinical study on screening and management of high-risk HPV infections and cervical lesions in postmenopausal women. Chin J Practical Gynecol Obstet [J]. 2025;41(5):548\u201352.","journal-title":"Chin J Practical Gynecol Obstet [J]"},{"issue":"12","key":"4622_CR17","first-page":"1820","volume":"48","author":"X Li","year":"2023","unstructured":"Li X, et al. High-grade cervical lesions diagnosed by JAM3\/PAX1 methylation in high-risk human papillomavirus-infected patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(12):1820\u20139.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"4622_CR18","first-page":"636","volume":"20","author":"CHEN Xinxin","year":"2025","unstructured":"Xinxin CHEN, Zhifang CHEN. Research progress of cervical cancer and precancerous lesions screening. China Med [J]. 2025;20(4):636\u201340.","journal-title":"China Med [J]"},{"issue":"11","key":"4622_CR19","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3390\/ijms26115205","volume":"26","author":"P Sustova","year":"2025","unstructured":"Sustova P, et al. The Predictive Impact of HPV Genotypes, Tumor Suppressors and Local Immune Response in the Regression of Cervical Intraepithelial Neoplasia 2\u20133: A Prospective Population-Based Cohort Study. Int J Mol Sci. 2025;26(11):5205. https:\/\/doi.org\/10.3390\/ijms26115205.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4622_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s12879-025-11128-6","volume":"25","author":"H Ding","year":"2025","unstructured":"Ding H, Jin H, Tang Y. HPV genotype distribution and cervical lesions in Chongqing: a comprehensive analysis of 229,770 females (2015\u20132023). BMC Infect Dis. 2025;25(1):760.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"4622_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/dc.25461","volume":"53","author":"J Zhou","year":"2025","unstructured":"Zhou J, et al. The Value of P16 Protein Detection in the Screening for High-Grade Squamous Intraepithelial and Higher Lesions of the Cervix by the Combined Detection of HR-HPV and TCT. Diagn Cytopathol. 2025;53(6):283\u20139.","journal-title":"Diagn Cytopathol"},{"issue":"20","key":"4622_CR22","first-page":"1852","volume":"104","author":"X Shang","year":"2024","unstructured":"Shang X, et al. [A multicenter study on the accuracy of PAX1\/JAM3 dual genes methylation testing for screening cervical cancer]. Zhonghua Yi Xue Za Zhi. 2024;104(20):1852\u20139.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"4622_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13148-024-01804-w","volume":"16","author":"J Fei","year":"2024","unstructured":"Fei J, et al. Evaluating PAX1\/JAM3 methylation for triage in HPV 16\/18-infected women. Clin Epigenetics. 2024;16(1):190.","journal-title":"Clin Epigenetics"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04622-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:37:03Z","timestamp":1788910623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04622-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4622"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04622-9","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the First Hospital of Hebei Medical University (Ethics Number: V1.0, 20221107). Initially, approval was granted for a pilot cohort of 100 participants. To ensure adequate statistical power, additional approval was obtained to expand the cohort to 409 participants. Written informed consent was obtained from all participants at the time of enrolment, and all samples were collected in compliance with ethical guidelines. This study, involving human participants and identifiable data, was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"447"}}